BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Feb. 6, 2017
View Archived Issues
Elekta secures FDA clearance for Venezia cervical cancer treatment device
Elekta AB has received FDA clearance for its Venezia applicator for gynecological brachytherapy. The device is positioned to treat advanced-stage cervical cancer and has had a CE mark since last year.
Read More
Wearable micropump from Cambridge cluster disrupts device design
Read More
Questions about device class persist regarding accessory guidance final
Read More
Seroba raises $108M in first close of third fund
Read More
Appointments and advancements
Read More
Financings
Read More
Product briefs
Read More
MDD's Stock Report
Read More
Other news to note
Read More
MDD's Neurology Extra
Read More